369 related articles for article (PubMed ID: 24486844)
1. [Sentinel lymph node status and axillary lymph node dissection in the surgical treatment of breast cancer].
Cserni G
Orv Hetil; 2014 Feb; 155(6):203-15. PubMed ID: 24486844
[TBL] [Abstract][Full Text] [Related]
2. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
3. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy and axillary dissection in breast cancer: results in a large series.
Veronesi U; Paganelli G; Viale G; Galimberti V; Luini A; Zurrida S; Robertson C; Sacchini V; Veronesi P; Orvieto E; De Cicco C; Intra M; Tosi G; Scarpa D
J Natl Cancer Inst; 1999 Feb; 91(4):368-73. PubMed ID: 10050871
[TBL] [Abstract][Full Text] [Related]
5. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East.
Imoto S; Hasebe T
Jpn J Clin Oncol; 1999 Jan; 29(1):11-5. PubMed ID: 10073145
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
Giuliano AE; Kirgan DM; Guenther JM; Morton DL
Ann Surg; 1994 Sep; 220(3):391-8; discussion 398-401. PubMed ID: 8092905
[TBL] [Abstract][Full Text] [Related]
7. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma.
Dale PS; Williams JT
Am Surg; 1998 Jan; 64(1):28-31; discussion 32. PubMed ID: 9457034
[TBL] [Abstract][Full Text] [Related]
8. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
Chu KU; Turner RR; Hansen NM; Brennan MB; Bilchik A; Giuliano AE
Ann Surg; 1999 Apr; 229(4):536-41. PubMed ID: 10203087
[TBL] [Abstract][Full Text] [Related]
9. Sentinel node localization and biopsy in breast cancer.
Howard-Alpe G
Clin Oncol (R Coll Radiol); 1999; 11(2):111-7. PubMed ID: 10378637
[TBL] [Abstract][Full Text] [Related]
10. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Donker M; van Tienhoven G; Straver ME; Meijnen P; van de Velde CJ; Mansel RE; Cataliotti L; Westenberg AH; Klinkenbijl JH; Orzalesi L; Bouma WH; van der Mijle HC; Nieuwenhuijzen GA; Veltkamp SC; Slaets L; Duez NJ; de Graaf PW; van Dalen T; Marinelli A; Rijna H; Snoj M; Bundred NJ; Merkus JW; Belkacemi Y; Petignat P; Schinagl DA; Coens C; Messina CG; Bogaerts J; Rutgers EJ
Lancet Oncol; 2014 Nov; 15(12):1303-10. PubMed ID: 25439688
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Upfront Surgical Management of the Axilla in Patients with Breast Cancer.
Williams AD; Weiss A
Clin Breast Cancer; 2024 Jun; 24(4):271-277. PubMed ID: 38220539
[TBL] [Abstract][Full Text] [Related]
12. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy.
Feldman SM; Krag DN; McNally RK; Moor BB; Weaver DL; Klein P
J Am Coll Surg; 1999 Mar; 188(3):248-54. PubMed ID: 10065813
[TBL] [Abstract][Full Text] [Related]
13. Treatment of the axilla in patients with primary breast cancer and low burden axillary disease: Limitations of the evidence from randomised controlled trials.
Robertson JF; Herrod PJ; Matthew J; Kilburn LS; Coles CE; Bradbury I
Crit Rev Oncol Hematol; 2017 Feb; 110():74-80. PubMed ID: 28109407
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node involvement--a predictor for axillary node status with breast cancer--has the time come?
Koller M; Barsuk D; Zippel D; Engelberg S; Ben-Ari G; Papa MZ
Eur J Surg Oncol; 1998 Jun; 24(3):166-8. PubMed ID: 9630852
[TBL] [Abstract][Full Text] [Related]
15. Reliability of sentinel node status in predicting axillary lymph node involvement in breast cancer.
Kollias J; Gill PG; Chatterton BE; Hall VE; Bochner MA; Coventry BJ; Farshid G
Med J Aust; 1999 Nov; 171(9):461-5. PubMed ID: 10615338
[TBL] [Abstract][Full Text] [Related]
16. Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.
Cserni G
Pathol Oncol Res; 1999; 5(2):129-33. PubMed ID: 10393365
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic axillary exploration and sentinel lymphadenectomy.
Tsangaris TN; Trad K; Brody FJ; Jacobs LK; Tsangaris NT; Sackier JM
Surg Endosc; 1999 Jan; 13(1):43-7. PubMed ID: 9869687
[TBL] [Abstract][Full Text] [Related]
18. Improved staging of breast cancer through lymphatic mapping and sentinel node biopsy.
Jansen L; Nieweg OE; Valdés Olmos RA; Rutgers EJ; Peterse JL; de Vries J; Doting MH; Kroon BB
Eur J Surg Oncol; 1998 Oct; 24(5):445-6. PubMed ID: 9800978
[TBL] [Abstract][Full Text] [Related]
19. [Sentinel node detection in breast carcinoma].
Hohenberger P; Reuhl T; Markwardt J; Schlag PM
Chirurg; 1998 Jul; 69(7):708-16. PubMed ID: 9738215
[TBL] [Abstract][Full Text] [Related]
20. Axillary lymph node dissection: Dead or still alive?
Beck AC; Morrow M
Breast; 2023 Jun; 69():469-475. PubMed ID: 36702672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
